CAF-induced neutropenia showed a trend to lower frequency in the IMS group. mistletoe thereapy breast cancer randomized clinical trial quality of life neutropenia pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppre
← all excerpts
Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone.
1
—
—